Biologics CDMO Secondary Packaging Market Trends & Size 2026-2035

Biologics CDMO Secondary Packaging Market Size and Segments Outlook (2026–2035)

The global biologics CDMO secondary packaging market, valued at USD 2.59 billion in 2025, is anticipated to reach USD 5.99 billion by 2035, growing at a CAGR of 8.75% over the next decade. Coverage includes value chain analysis, supply chain logistics, cold chain packaging requirements, manufacturing ecosystem, and profiles of leading global suppliers and CDMOs. Regional data spans NA, EU, APAC, Latin America, and Middle East & Africa, with statistical clarity.

1. Executive Summary

1.1 Market Overview (secondary packaging solutions for biologics in CDMO operations)
1.2 Key Market Highlights
1.3 Demand Drivers Snapshot (growth in biologics, outsourcing, cold chain needs)
1.4 Strategic Insights

2. Market Definition & Scope

2.1 Definition of Biologics CDMO Secondary Packaging
2.2 Scope of Study (outsourced secondary packaging for biologics)
2.3 Industry Ecosystem Mapping
2.4 Value Chain Overview
2.5 Strategic Insights

3. Market Structure & Industry Overview

3.1 Market Taxonomy
3.2 Value Chain Analysis

  • Raw Material Suppliers
  • Packaging Manufacturers
  • CDMOs (Contract Development & Manufacturing Organizations)
  • Biopharmaceutical Companies

3.3 Supply Chain Analysis
3.4 Packaging Process Overview (labeling, cartoning, serialization)
3.5 Cost Structure Analysis
3.6 Margin Analysis
3.7 Strategic Insights

4. Market Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges
4.5 Strategic Insights

5. Technology & Innovation Analysis

5.1 Automated Cartoning & Packaging Systems
5.2 Serialization & Track-and-Trace Technologies
5.3 Cold Chain Compatible Secondary Packaging
5.4 Smart & Connected Packaging Solutions
5.5 Sustainable & Recyclable Materials
5.6 Strategic Insights

6. Segmentation Analysis

6.1 By Product Type

6.1.1 Boxes
6.1.2 Cartons

6.2 By Primary Package Type

6.2.1 Ampoules
6.2.2 Blister Packs
6.2.3 Bottles
6.2.4 Cartridges
6.2.5 Syringes and Vials
6.2.6 Prefilled Syringes

6.3 Strategic Insights

7. End-use Industry Analysis

7.1 Biopharmaceutical Companies
7.2 Contract Development & Manufacturing Organizations (CDMOs)
7.3 Vaccine Manufacturers
7.4 Biosimilars & Specialty Drugs
7.5 Strategic Insights

8. Regional Analysis

8.1 North America

  • U.S.
  • Canada

8.2 Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway

8.3 Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Thailand

8.4 Latin America

  • Brazil
  • Mexico
  • Argentina

8.5 Middle East and Africa (MEA)

  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait

9. Industry Ecosystem Analysis

9.1 CDMO Packaging Service Providers
9.2 Integration with Biologics Manufacturing
9.3 Regulatory Compliance (GMP, serialization mandates)
9.4 Cold Chain Logistics & Distribution
9.5 Strategic Insights

10. Competitive Landscape

10.1 Market Structure Overview
10.2 Competitive Benchmarking
10.3 Strategic Developments
10.4 Mergers & Acquisitions
10.5 Strategic Insights

11. Key Companies Profiled

11.1 Cavanna Packaging Group
11.2 Loesch Verpackungstechnik GmbH
11.3 Theegarten-Pactec
11.4 Bradman Lake Group
11.5 FUJI MACHINERY CO., LTD.
11.6 Tecno Pack Spa

12.1 Growth in Biologics Manufacturing Capacity
12.2 Increasing Outsourcing to CDMOs
12.3 Investments in Automation & Serialization
12.4 Expansion of Cold Chain Infrastructure
12.5 Strategic Insights

13. Market Opportunity Analysis

13.1 Rising Demand for Biologics & Biosimilars
13.2 Growth in Injectable Drug Packaging
13.3 Expansion in Emerging Markets
13.4 Increasing Regulatory Requirements
13.5 Strategic Insights

14. Risk Analysis

14.1 Regulatory Compliance Risks
14.2 Cold Chain Disruptions
14.3 High Operational Costs
14.4 Supply Chain Constraints
14.5 Strategic Insights

15. Porter’s Five Forces Analysis

15.1 Competitive Rivalry
15.2 Threat of New Entrants
15.3 Supplier Power
15.4 Buyer Power
15.5 Threat of Substitutes

16. PESTLE Analysis

16.1 Political Factors
16.2 Economic Factors
16.3 Social Factors
16.4 Technological Factors
16.5 Legal Factors
16.6 Environmental Factors

17. Future Outlook & Strategic Recommendations

17.1 Market Growth Outlook
17.2 Increasing Role of CDMOs in Packaging
17.3 Adoption of Smart & Sustainable Packaging
17.4 Expansion in Asia Pacific
17.5 Strategic Recommendations
17.6 Final Insights

Meet the Team

Vidyesh Swar

Vidyesh Swar

Principal Research Analyst

Vidyesh Swar is a Senior Research Analyst at Towards Packaging, bringing over 4 years of dedicated expertise in market intelligence and strategic analysis across the dynamic world of packaging technologies and solutions.

Learn more about Vidyesh Swar
Aditi Shivarkar

Aditi Shivarkar

Reviewed By

Aditi Shivarkar, with 14+ years in packaging market research, specializes in food, beverage, and eco-friendly packaging. She ensures accurate, actionable insights, driving Towards Packaging Analytics & Consulting 's excellence in industry trends and sustainability.

Learn more about Aditi Shivarkar

FAQ's

Answer : The biologics CDMO secondary packaging market reached US$ 2.38 billion in 2024 and is projected to hit around US$ 5.50 billion by 2034.

Answer : 8.75% is the growth rate of the biologics CDMO secondary packaging industry.

Answer : North America region leads the global biologics CDMO secondary packaging market.